// App-Quantinova.ai

2676 : High-Dose Vincristine Sulfate Liposome Injection (Marqibo) Is Not Associated With Clinically Meaningful Hematologic Toxicity

Researchers

Presenter

  • Olivia R. Deitcher

Principal Investigators

  • John Glaspy

  • Rene Gonzalez

  • Takami Sato

  • Agop Bedikian

  • Karen Segarini

  • Jeffrey A. Silverman

  • Steven R. Deitcher

Medical Centers

  • University of Colorado Cancer Center, Aurora, CO

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • UCLA School of Medicine, Los Angeles, CA

  • Thomas Jefferson University, Philadelphia, PA

Locations

  • United States

Companies

  • Talon Therapeutics,

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Hematological malignancies

  • Thrombocytopenia

  • Uveal melanoma

  • Neutropenia

  • Lymphomas

  • Melanoma

  • Anemia

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Vincristine

  • CVac

Outcome

  • N/A

Study Design

  • pharmacokinetics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved